Watertown, MA, May 30, 2024 – Exergen Corporation, a leader in infrared temperature measurement technologies, announced today that it has been granted a new patent for innovative devices and methods aimed at detecting inflammation, specifically designed to help diabetes patients monitor their health. The patent, titled “Devices and Methods for Detecting Inflammation,” represents a significant advancement in non-invasive medical diagnostics.